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ABSTRACT 
A	repository	of	clinically	associated	Staphylococcus	aureus	(Sa)	iso‐
lates	is	used	to	semi‐automatically	generate	a	set	of	application	ontolo‐
gies	 for	 specific	 subfamilies	 of	 Sa‐related	 disease.	 Each	 such	 applica‐
tion	ontology	is	compatible	with	the	Infectious	Disease	Ontology	(IDO)	
and	uses	resources	from	the	Open	Biomedical	Ontology	(OBO)	Found‐
ry.	The	set	of	application	ontologies	 forms	a	 lattice	structure	beneath	
the	 IDO‐Core	 and	 IDO‐extension	 reference	 ontologies.	We	 show	 how	
this	 lattice	 can	 be	 used	 to	 define	 a	 strategy	 for	 the	 construction	 of	 a	
new	 taxonomy	of	 infectious	disease	 incorporating	genetic,	molecular,	
and	clinical	data.	We	also	outline	how	 faceted	browsing	and	query	of	
annotated	data	is	supported	using	a	lattice	application	ontology.				
1 INTRODUCTION 
One of the more ambitious goals of current clinical and bi-
omedical research is the personalization of medicine, in 
which treatments are selected on the basis of patient-specific 
as well as disease-specific information. Recent advances in 
high-throughput technologies have resulted in a push for the 
use of patient-specific information in care decisions, par-
ticularly genomic and functional genomic data, but also 
proteomic, metabolomic, and cytometry data. It is widely 
believed that the increased precision of personalized medi-
cine will yield more effective treatments, with better out-
comes and fewer adverse side effects.  
    Personalized medicine requires that genomic (and other) 
data be effectively classified and associated with known 
clinical phenotypes and disease types. Currently available 
taxonomies of disease do not support this, however, and are 
in general not well suited for integration and analysis of 
high-throughput molecular and cellular data with clinical 
data, such as the data found in electronic medical records. 
Current disease taxonomies were developed primarily to 
support diagnosis and reimbursement coding rather than as 
biological representations of disease. As a consequence, 
they are based on single, rigid hierarchies that do not reflect 
the complex interconnections between disease types; they 
lack links to molecular- and cellular-level data and infor-
mation; and they lack the sort of formal structure that would 
support their use for the kinds of computational analyses 
applied in biological and clinical research. For example, the 
International Classification of Disease (ICD) version 9 in-
cludes catch-all codes such as “[041.19] Other Staphylococ-
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cus” and scattered exclusions such as “[041] Bacterial infec-
tion in conditions classified elsewhere and of unspecified 
site. Excludes: septicemia (038.0 – 038.9)”.  
The National Academies of Science have recently called 
for a new taxonomy of disease, along with informatics tools 
to support its construction (Committee on the Framework 
for Developing a New Taxonomy of Disease, 2011). In sup-
port of such a taxonomy, an information commons would be 
developed to store “bedside” clinical data collected during 
clinical encounters, effectively treating each patient as a 
participant in a clinical study, and integrate this information 
in a knowledge network that would formalize the relation-
ships between different disease data sets. The long-term 
goal is to produce the new taxonomy of disease from a vali-
dated subset of the knowledge network. 
We believe that biomedical ontologies will be essential to 
the construction of the envisioned taxonomy of disease, 
especially the ontologies in the Open Biomedical Ontology 
(OBO) Foundry (Smith et al., 2007). The OBO Foundry 
(OBOF) represents a coordinated effort to construct refer-
ence biomedical ontologies according to best practices and 
principles and to use these ontologies as the basis for 
OBOF-conformant application ontologies. The coordinated 
development of these ontologies and their use of a common 
formalism increases data interoperability and consistency 
for datasets annotated in their terms. The use of OBOF on-
tologies in construction of the new disease taxonomy can 
bring significant benefits. For example, the widespread use 
of OBOF ontologies for data annotation would link the dis-
ease taxonomy to many existing databases and information 
resources, and their underlying formalism allows the dy-
namic inference of different views and multiple intercon-
nected hierarchies. In addition, many analysis algorithms for 
high-throughput data already utilize these ontologies. 
The Infectious Disease Ontology (IDO) suite of ontolo-
gies is being developed within the OBO Foundry framework 
and includes a hub – the IDO-Core – consisting of terms 
and relations relevant to infectious diseases generally, to-
gether with a set of disease-specific extensions derived 
therefrom. The IDO ontologies are interoperable and jointly 
cover the infectious disease domain. Here we illustrate how 
the IDO ontologies can be used in the construction of a part 
of the new taxonomy of disease and to integrate clinically 
relevant phenotypic and genotypic data.  
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We take as our case study infectious diseases caused by 
Staphylococcus aureus (Sa) infection. We show how isolate 
data from the Network on Antimicrobial Resistance in 
Staphylococcus aureus (NARSA) can be annotated using 
IDO and its extensions. We then demonstrate a faceted 
browser in which both phenotypic and genotypic aspects of 
the IDO-annotated isolate data can be exposed and queried. 
Our goal is to provide a resource from which an IDO-
conformant application ontology can be derived for a specif-
ic Sa infectious disease type. Such application ontologies 
can be generated in a semi-automated way and collectively 
form a lattice structure beneath IDO-Core (described be-
low). While our example narrowly focuses on properties of 
infectious agents, this effort is part of a larger effort to cre-
ate an ontological representation of Sa diseases, and we be-
lieve the same approach can be applied to host data and to 
the integration of host and pathogen data.  
2 INFECTIOUS DISEASE ONTOLOGY 
IDO-Core includes terms relevant for infectious diseases 
generally, terms such as ‘host’, ‘infectious agent’, ‘fomite’, 
and ‘virulence factor’, and the relations between the corre-
sponding types. Disease- and pathogen-specific extensions 
are developed by extending the core to include terms and 
relations relevant to the corresponding infectious disease(s). 
For example, the IDO extension for Sa (IDO-Sa) includes 
terms such as ‘Staphylococcus aureus bacteremia’ and 
‘Staphylococcal cassette chromosome mec’.  
IDO extensions are currently being developed for influ-
enza, malaria, brucellosis, HIV, and Sa. Further extensions 
will involve the creation of specific application ontologies 
by IDO user groups. It will be necessary for these ontologies 
to import terms from several OBO Foundry ontologies, as 
well as from existing IDO extension ontologies. This will 
give rise to a lattice structure beneath IDO core and its ex-
tensions, as illustrated in Figure 1. At the bottom of the lat-
tice is IDO-ALL, the (pre-inference) closure of possible the 
IDO ontologies. 
When a new application ontology is needed, its position 
in the lattice will be determined by the terms it needs to im-
port. IDO Core is agnostic to biological scale, host organ-
ism, and disciplinary perspective, but it will be desirable for 
some of the application ontologies in the lattice to hold 
some of these fixed (e.g., genetic aspects of influenza in 
birds), thus serving as granular partitions of the domain on-
tology they are extending. The lattice serves as a representa-
tion of some of the interdependencies in the existing IDO 
set of ontologies and the intended overall domain coverage. 
 
 
Fig 1. A possible lattice expansion of IDO 
2.1 OGMS/IDO Disease Model 
The IDO ontologies represent disease according to the dis-
order – disease – disease course framework provided by the 
Ontology for General Medical Science (OGMS), in which a 
disorder is the physical basis of a disease, which is itself a 
disposition to pathological processes realized in a disease 
course. For example, in IDO-Sa we assert the following in 
OWL-DL: 
 Sa subClassOf obi:organism AND  
ido:‘infectious agent’ 
 SaI =def ido:‘infectious disorder’ AND 
has_part SOME Sa 
 SaID =def ido:‘infectious disease’ AND 
has_material_basis_in SOME SaI. 
 SaID realized_by ONLY SaIDC 
where, ‘Staphylococcus aureus’ = Sa, ‘Sa Infectious Disor-
der’ = SaI,‘Sa Infectious Disease’ = SaID, and ‘Sa Infec-
tious Disease Course’=SaIDC. 
The primary classification of Sa is as an organism, but Sa 
bacteria are also infectious agents because they have a dis-
position to cause infectious disease in some hosts. Note we 
define Sa infectious disorder as an infectious disorder that 
has Sa as part, but we do not assert “Sa part_of SOME SaI” 
because Sa can be among a host’s normal flora, for example 
on the skin or nasal mucosa. 
We use the shortcut relation has_material_basis here to 
establish a link between the disease (disposition) and the 
disorder (material entity) (Goldfain, Smith and Cowell, un-
der review). An infectious disorder is both an infection (a 
material entity composed of infectious agents) and a disor-
der (has reached the threshold of clinical significance to 
dispose a host to infectious disease).  
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2.2 Classifying Staphylococcus aureus diseases 
Infectious diseases can usefully be classified in terms of a 
number of differentia, including:  host type, (sub-)species of 
infectious agent, route of transmission, antibiotic resistance, 
and anatomical site of infection. 
For many species of infectious agent, including Sa, a fur-
ther classification into strain categories is useful. Many dif-
ferent typing systems are used, including: Pulse Field Gel 
Electrophoresis (into strains), Multi-Locus Sequence Typing 
(into sequence types), BURST Clustering (into clonal com-
plexes), and gram staining (into gram positive and gram 
negative classes). Each of these typing systems is tied to a 
particular type of assay that can be described using the On-
tology for Biomedical Investigations (OBI). 
For our present purpose, we are interested in a typing 
system specifically created to differentiate Sa isolates, the 
Staphylococcal cassette chromosome mec (SCCmec) typing 
system. SCCmec is further differentiated by its subparts: (a) 
Cassette chromosome recombinases (ccr) and (b) mec gene 
complex (mec). The SCCmec is a mobile genetic element 
that carries the central determinant for broad-spectrum beta-
lactam antibiotic resistance encoded by the mecA gene 
(Katayama, Ito and Hiramatsu, 2000). The genetic charac-
teristics of SCCMec are of critical importance to the type of 
treatment and Sa disease course an infected host may under-
go. The International Working Group on the Staphylococcal 
Cassette Chromosome elements1 maintains a list with defi-
nitions of the latest known SCCmec types. At the time of 
this writing, there are 11 known SCCmec types. We include 
this information in IDO-Sa by leveraging the Sequence On-
tology (SO) to assert the following:  
 
 SCCMec subClassOf so:gene_cassette 
 SCCMec subClassOf so:mobile_genetic_element 
 ‘mec gene complex’ subClassOf 
so:gene_cassette_member 
 ‘ccr gene complex’ subClassOf 
so:gene_cassette_member 
 SCCMec has_part SOME ‘mec gene complex’ 
 SCCMec has_part SOME ‘ccr gene complex’ 
 
The classification of SCCmec as a gene cassette is to be 
preferred over its classification as a mobile genetic element 
because the former tells us what SCCmec is, while the latter 
tells us what SCCmec can do. However, we include both 
here, because most descriptions of SCCmec highlight its 
mobility. Description of a SCCMec subtype then proceeds 
as follows: 
 
 SCCMecIV subClassOf SCCMec 
 ‘mec Class B’ subClassOf ‘mec gene complex’ 
 ‘ccr Type 2’ subClassOf ‘ccr gene complex’ 
 SCCMecIV has_part SOME ‘mec Class B’ 
  
1 http://www.sccmec.org/Pages/SCC_ClassificationEN.html  
 SCCMecIV has_part SOME ‘ccr Type 2’ 
 
More fine grained sequence information about the ccr and 
mec complexes can be captured using SO terms and rela-
tions.  
3 CASE STUDY   
We will now show how a lattice of Sa isolates can be con-
structed using IDO-Sa and isolate metadata indicating prop-
erties such as the mec and ccr gene complex types.  The 
isolate lattice is then used as the basis for our desired lattice 
of infectious disease application ontologies. Ontologically 
speaking, isolates are particulars that instantiate the organ-
ism type Sa and have been extracted from a host organism. 
Here we do not represented the distinctions between Sa as 
an ‘isolate’ or as part of a ‘cell culture’, however we believe 
these terms are general enough to infectious disease re-
search to warrant inclusion in IDO-Core.  
The ontology generated for this case study is stored 
across several OWL files. The full ontology, including ex-
ternal imports and automatically generated isolate infor-
mation is currently available in OWL-DL format at 
http://www.awqbi.com/LATTICE/narsa-complete.owl. The 
ontology was developed using Protege 4.1 and was checked 
for inconsistency using the Hermit 1.3.5 and Fact++ reason-
ers. 
3.1 Resources 
Wherever possible, we import and reuse terms (and URIs) 
from OBO Foundry ontologies via the MIREOT technique 
(Courtot et al., 2011) and use relations from the OBO rela-
tion ontology (RO) or proposed extensions thereto. The 
OBO Foundry ontologies we require for our case study are: 
Ontology for General Medical Science (OGMS2), Ontology 
for Biomedical Investigations (OBI3), Sequence Ontology 
(SO), Infectious Disease Ontology (IDO4), Information Ar-
tifact Ontology (IAO5), NCBI Taxonomy (NCBITaxon6), 
and Foundational Model of Anatomy (FMA7). 
We also import drug file names from the National Drug 
File Reference Terminology (NDF-RT) to represent antibi-
otic resistance, and create links to two other resources: (1) 
Antibiotic Resistance Ontology8 and  Antibiotic Resistance 
Database Ontology9. Various other stakeholders (such as the 
DebugIT European Union initiative) have ontologies and 
databases of antimicrobial resistance, but we only to link to 
open resources for our case study. 
 
  
2 http://code.google.com/p/ogms/  
3 http://obi-ontology.org/page/Main_Page  
4 http://infectiousdiseaseontology.org/page/Main_Page  
5 http://code.google.com/p/information-artifact-ontology/  
6 http://www.ncbi.nlm.nih.gov/Taxonomy/  
7 http://sig.biostr.washington.edu/projects/fm/  
8 http://arpcard.mcmaster.ca 
9 http://ardb.cbcb.umd.edu/antibio_resis.obo 
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3.2 NARSA Isolate Repository 
The Network on Antimicrobial Resistance in Staphylococ-
cus aureus10 maintains a repository of Sa isolates for clinical 
research which includes genetic, phenotypic, and demo-
graphic information on each isolate. For this example, we 
use a subset of 101 NARSA isolates, those listed in the 
“Known Clinically Associated Strains – ABCs Collection 
from CDC” repository. All of the isolates in this subset have 
an SCCMec type annotation in the NARSA repository and 
have diverse geographic origin in the United States.11  
The NARSA subset was selected to demonstrate how a 
disease lattice could be constructed starting from only struc-
tured HTML content about isolates. NARSA maintains a 
database of extended information about such isolates; how-
ever we only used the information publicly available on the 
web. 
A script was created to extract each isolate’s NARSA id 
(NRSnnn), culture source, toxin profile, and antimicrobial 
profile. The script was implemented in Ruby and utilized 
the Hpricot HTML library and regular expressions to extract 
information. First, the NARSA id was used to assert the 
existence of a Sa instance type. Then the culture source data 
was extracted. The culture source was sometimes unspeci-
fied (‘other’) or underspecified (‘blood’ vs ‘wound’). Only 
culture sources for which FMA types existed were asserted 
to exist as such, but IDO allows for an even more complete 
representation of host anatomical entities if such infor-
mation is known. For example, the anatomical location from 
which the infectious organism is isolated may also be a por-
tal of entry. 
The toxin profile for NARSA subset isolates included the 
presence or absence of the Panton Valentine Leukocidin 
(PVL) and Toxic Shock Syndrome Toxin (TSST). These 
toxins are strong determinants of  the virulence and clinical 
manifestation of Sa disease. We classify PVL and TSST as 
ido:exotoxin. The presence or absence of a toxin is not usu-
ally associated with drug resistance, but by representing 
both pieces of information we are able to query the applica-
tion ontology for correlations between the presence of tox-
ins and resistance to certain drug types. 
The antimicrobial profile for the NARSA subset includes 
15 drugs (see Figure 2 for a subset of these). For each drug, 
NARSA reports a minimum inhibitory concentration – a 
range or exact value – along with an interpretation of the 
antibiotic resistance indicated by this value following the 
Clinical and Laboratory Standards Institute guidelines. 
 
  
10 See http://www.narsa.net/  
11 See http://www.cdc.gov/abcs/reports-findings/surv-reports.html  
 
Fig 2. Antimicrobial profile for an isolate in the NARSA subset 
 
The NDF-RT was used to validate this profile by making 
sure that the set of drugs in the profile  is a subset of: 
  
{d | ndf-rt:’Staph Infection’ ndf-rt:may_be_treated_by d} 
 
For NARSA, or any other resource on antimicrobial re-
sistance, there may be a good reason to restrict attention to a 
subset of antimicrobials. However, since new resistance 
evolves rapidly, a resource such as NDF-RT can be used to 
synchronize the latest antibiotics permissible in such a pro-
file.  
Minimum inhibitory concentration data (MIC) are repre-
sented using IAO and OBI as follows: 
 
 ‘MIC assay’ subclassOf iao:assay 
 ‘MIC assay’ has_specified_output SOME  
‘MIC data item’ 
 ‘MIC scalar measurement datum’ is_about SOME  
‘drug susceptibility of infectious agent’ 
   
Resistance is a disposition that an infectious agent bears 
towards some drugs and is realized in their presence. We 
have elsewhere modeled resistance in terms of pairwise 
complementary dispositions on the part of both the infec-
tious agent and the drug (Goldfain, Smith & Cowell, 2011).  
Here we link resistance to MIC measurement data using the 
shortcut relation has_qualitative_basis as follows: 
 
 ido:’resistance to drug’ has_qualitative_basis 
SOME (is_quality_measured_as SOME ‘MIC 
measurement datum’) 
 
Finally, for each drug D towards which the isolate Sa has 
a drug resistance we assert: 
 
 ‘resistance to D’ subclassOf  
ido:‘resistance to drug’  
 Sa has_disposition SOME ‘resistance to D’ 
 
3.3 From an Isolate Lattice to a Disease Lattice 
The lattice of infectious diseases mirrors the isolate lattice 
by representing the types of infectious disease different iso-
lates can give rise to. Infectious agents are parts of those 
infectious disorders which are the material basis for infec-
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tious disease. Using the representation developed above, we 
can begin to make assertions about the specific types of dis-
ease the isolates give rise to and the profiles of the disease 
courses which realize these diseases. For example, the pres-
ence of the PVL toxin in Sa can lead to necrotic lesions 
(ogms:disorder) and necrotizing pneumonia (ogms:disease).  
4 FACETED BROWSING OF THE LATTICE 
A faceted browser of the ontologically annotated NARSA 
isolates was constructed using the MIT Exhibit 2.0 library 
(http://www.awqbi.com/LATTICE/narsa-complete.html). 
This tool allows the user to visualize and correlate isolate 
information across different dimensions (see Figure 3). 
 
Fig 3. Faceted browsing illustrates that most isolates with a re-
sistance to Clindamycin are of SCCmec type II and lack PVL 
 
Linking to external resources is facilitated by the fact that 
such facets are assigned ontology types from the IDO lat-
tice. These are exactly the kinds of links that will be needed 
for the knowledge network supporting a new taxonomy of 
disease.  
5 CONCLUSION 
A lattice of infectious disease ontologies can serve as a 
mechanism to integrate pathogen-specific typing systems 
such as SCCMec with phenotypic data such as drug re-
sistance. Such genotype-phenotype relations will be the key 
to a more effective taxonomy of disease that enables truly 
personalized medicine. The lattice of infectious diseases is 
expected to grow along predictable dimensions (host organ-
ism, infectious agent organism, drug resistance), but can 
accommodate lightweight application ontologies that are 
created for very specific purposes. Each such application 
ontology will have a place in the lattice on the basis of what 
IDO terms it imports.  
We have shown that IDO-conformant annotation of iso-
late data (such as that in the NARSA repository) is possible 
without the need to reassemble OBO Foundry resources for 
new applications. Other benefits of our approach include: 
exposing currently accepted SCCmec types in a computable 
format via an ontology and validating the NARSA antimi-
crobial profile using the NDF-RT.   
We hope to reuse a similar technique to that outlined in 
this paper for isolate repositories across the infectious dis-
ease domain. In so doing, we hope to broaden the lattice and 
integrating organism specific typing systems with the IDO 
suite of ontologies. We believe that such an effort can be a 
powerful enabler for a new taxonomy of infectious disease 
and its supporting knowledge network.  
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